no abstract
-
2008 (v1)Journal articleUploaded on: December 3, 2022
-
2000 (v1)Conference paper
European Journal of Nuclear Medecine 27(8):1144
Uploaded on: December 3, 2022 -
September 2011 (v1)Conference paper
International audience
Uploaded on: December 4, 2022 -
2011 (v1)Journal article
Germline mutations in BRCA1/2 confer a high risk of breast cancer (BC), but the magnitude of this risk varies according to various factors. Although controversial, there are data to support the hypothesis of allelic-risk heterogeneity. We assessed variation in BC risk according to the location of mutations recorded in the French study GENEPSO....
Uploaded on: December 3, 2022 -
October 18, 2017 (v1)Conference paper
Many researches have been conducted in the last decades on the determination of the minimal clinically important difference(MCID) for health-related quality of life (HRQOL) scores. Several methods have been proposed, generally classified in distribution oranchor-based methods. A joint use of both distribution and anchorbased approaches, using...
Uploaded on: December 3, 2022 -
September 21, 2011 (v1)Journal article
ABSTRACT: Perforin gene (PRF1) mutations have been identified in some patients diagnosed with the familial form of hemophagocytic lymphohistiocytosis (HLH) and in patients with lymphoma. The aim of the present study was to determine whether patients with a familial aggregation of hematological malignancies harbor germline perforin gene...
Uploaded on: December 4, 2022